Electrocardiographic remodeling in patients paced for heart failure

J Vogt1, O Krahnefeld, B Lamp

  • 1Department of Cardiology, Heart Center North Rhine-Westphalia, Ruhr University, Bad Oeynhausen, Germany.

Insights

Electrical resynchronization therapy can improve heart failure symptoms. Pacing-induced QRS width shortening correlates with improved peak oxygen uptake, serving as a noninvasive marker for treatment efficacy in heart failure patients.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure Management

Background:

  • Congestive heart failure (CHF) often presents with intraventricular conduction delays, impacting patient prognosis.
  • Electrical resynchronization therapy (ERT) is an emerging treatment to improve functional status in CHF patients.
  • Understanding the relationship between electrocardiographic (ECG) changes and hemodynamic improvements is crucial for optimizing ERT.

Purpose of the Study:

  • To evaluate the correlation between pacing-induced ECG changes and hemodynamic status in CHF patients.
  • To determine if ECG parameters can serve as noninvasive markers for ERT efficacy.
  • To assess the long-term effects of ERT on intrinsic ECG parameters.

Main Methods:

  • Analysis of ECG data from 42 CHF patients (NYHA class III-IV) in the Pacing Therapies in Congestive Heart Failure trial.
  • Measurement of QRS duration during intrinsic rhythm and various pacing modes (biventricular, left ventricular, right ventricular) with optimized atrioventricular delay.
  • Correlation of ECG measurements with functional outcomes, including peak oxygen uptake (VO2).

Main Results:

  • Right ventricular pacing significantly increased QRS duration by 40 msec compared to baseline or biventricular pacing.
  • Shortening of paced QRS width showed a significant positive correlation with increased peak VO2 (r = 0.55; p < 0.05).
  • No significant changes in intrinsic QRS width were observed after 12 months of follow-up, irrespective of underlying disease (coronary artery disease vs. dilated cardiomyopathy).

Conclusions:

  • Right ventricular pacing widens QRS duration in left bundle-branch block patients, unlike LV or biventricular pacing.
  • Paced QRS width reduction is a potential noninvasive marker for improved peak VO2 and clinical efficacy in ERT.
  • Long-term pacing does not appear to induce significant remodeling of the intrinsic ECG in CHF patients.

Related Concept Videos

Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...
Cardiac Action Potential01:30

Cardiac Action Potential

Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase of...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...